Operating Income (Loss) of HERON THERAPEUTICS, INC. /DE/ from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Operating Income (Loss) for the quarter ending 31 Dec 2025 was $38,000, a 99% decline year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ Operating Income (Loss) for the twelve months ending 31 Dec 2025 was $2,538,000, a 78% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ annual Operating Income (Loss) for 2025 was $2,538,000, a 78% increase from 2024.
  • HERON THERAPEUTICS, INC. /DE/ annual Operating Income (Loss) for 2024 was $11,528,000, a 90% increase from 2023.
  • HERON THERAPEUTICS, INC. /DE/ annual Operating Income (Loss) for 2023 was $110,615,000, a 37% increase from 2022.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $2,538,000 $38,000 -$4,135,000 -99% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $1,597,000 $4,093,000 +$365,000 +8.2% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,232,000 $1,637,000 +$4,808,000 +75% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $3,576,000 $3,154,000 +$7,952,000 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $11,528,000 $4,173,000 +$14,393,000 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $25,921,000 $4,458,000 +$20,471,000 +82% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 $46,392,000 $6,445,000 +$35,958,000 +85% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $82,350,000 $4,798,000 +$28,265,000 +85% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $110,615,000 $10,220,000 +$10,135,000 +50% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $120,750,000 $24,929,000 +$16,953,000 +40% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $137,703,000 $42,403,000 +$7,095,000 +14% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $144,798,000 $33,063,000 +$29,860,000 +47% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 $174,658,000 $20,355,000 +$33,182,000 +62% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $207,840,000 $41,882,000 +$9,826,000 +19% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $217,666,000 $49,498,000 +$10,971,000 +18% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $228,637,000 $62,923,000 -$10,809,000 -21% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $217,828,000 $53,537,000 +$7,759,000 +13% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $225,587,000 $51,708,000 +$6,676,000 +11% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $232,263,000 $60,469,000 -$4,720,000 -8.5% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $227,543,000 $52,114,000 +$620,000 +1.2% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $228,163,000 $61,296,000 -$1,934,000 -3.3% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2021 2020 FY
Q3 2020 $226,229,000 $58,384,000 -$23,531,000 -68% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $202,698,000 $55,749,000 -$3,970,000 -7.7% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $198,728,000 $52,734,000 +$11,966,000 +18% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $210,694,000 $59,362,000 -$8,048,000 -16% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $202,646,000 $34,853,000 +$6,927,000 +17% 01 Jul 2019 30 Sep 2019 10-K 24 Feb 2021 2020 FY
Q2 2019 $209,573,000 $51,779,000 -$12,926,000 -33% 01 Apr 2019 30 Jun 2019 10-K 24 Feb 2021 2020 FY
Q1 2019 $196,647,000 $64,700,000 -$12,710,000 -24% 01 Jan 2019 31 Mar 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 $183,937,000 $51,314,000 +$10,576,000 +17% 01 Oct 2018 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $194,513,000 $41,780,000 -$466,000 -1.1% 01 Jul 2018 30 Sep 2018 10-K 02 Mar 2020 2019 FY
Q2 2018 $194,047,000 $38,853,000 +$3,202,000 +7.6% 01 Apr 2018 30 Jun 2018 10-K 02 Mar 2020 2019 FY
Q1 2018 $197,249,000 $51,990,000 -$2,691,000 -5.5% 01 Jan 2018 31 Mar 2018 10-K 02 Mar 2020 2019 FY
Q4 2017 $194,558,000 $61,890,000 -$15,087,000 -32% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $179,471,000 $41,314,000 +$6,420,000 +13% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $185,891,000 $42,055,000 +$1,011,000 +2.3% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $186,902,000 $49,299,000 -$15,987,000 -48% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $170,915,000 $46,803,000 -$15,743,000 -51% 01 Oct 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
Q3 2016 $155,172,000 $47,734,000 -$25,243,000 -112% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2017 Q3
Q2 2016 $129,929,000 $43,066,000 -$20,052,000 -87% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $109,877,000 $33,312,000 -$12,952,000 -64% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $96,925,000 $31,060,000 -$11,565,000 -59% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $85,360,000 $22,491,000 -$3,538,000 -19% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 $81,822,000 $23,014,000 -$4,223,000 -22% 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016 2016 Q2
Q1 2015 $77,599,000 $20,360,000 -$3,038,000 -18% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $74,561,000 $19,495,000 -$5,663,000 -41% 01 Oct 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
Q3 2014 $68,898,000 $18,953,000 -$6,289,000 -50% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2015 Q3
Q2 2014 $62,609,000 $18,791,000 -$3,582,000 -24% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015 2015 Q2
Q1 2014 $59,027,000 $17,322,000 -$4,570,000 -36% 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015 2015 Q1
Q4 2013 $54,457,000 $13,832,000 -$5,204,000 -60% 01 Oct 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
Q3 2013 $49,253,000 $12,664,000 -$6,610,000 -109% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014 2014 Q3
Q2 2013 $42,643,000 $15,209,000 -$10,829,000 -247% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014 2014 Q2
Q1 2013 $31,814,000 $12,752,000 -$7,983,000 -167% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
Q4 2012 $23,831,000 $8,628,000 -$4,510,000 -110% 01 Oct 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
Q3 2012 $19,321,000 $6,054,000 -$1,965,000 -48% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3
Q2 2012 $17,356,000 $4,380,000 -$2,840,000 -184% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013 2013 Q2
Q1 2012 $14,516,000 $4,769,000 -$3,454,000 -263% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q1
Q4 2011 $11,062,000 $4,118,000 01 Oct 2011 31 Dec 2011 10-K 07 Mar 2014 2013 FY
Q3 2011 $4,089,000 -$2,454,000 -150% 01 Jul 2011 30 Sep 2011 10-Q 05 Nov 2012 2012 Q3
Q2 2011 $1,540,000 +$2,155,000 +58% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012 2012 Q2
Q1 2011 $1,315,000 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q1
Q3 2010 $1,635,000 01 Jul 2010 30 Sep 2010 10-Q 07 Nov 2011 2011 Q3
Q2 2010 $3,695,000 01 Apr 2010 30 Jun 2010 10-Q 08 Aug 2011 2011 Q2

HERON THERAPEUTICS, INC. /DE/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,538,000 +$8,990,000 +78% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $11,528,000 +$99,087,000 +90% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $110,615,000 +$64,043,000 +37% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 $174,658,000 +$43,170,000 +20% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $217,828,000 +$10,335,000 +4.5% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $228,163,000 -$17,469,000 -8.3% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $210,694,000 -$26,757,000 -15% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $183,937,000 +$10,621,000 +5.5% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $194,558,000 -$23,643,000 -14% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $170,915,000 -$73,990,000 -76% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $96,925,000 -$22,364,000 -30% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $74,561,000 -$20,104,000 -37% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017 2016 FY
2013 $54,457,000 -$30,626,000 -129% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $23,831,000 -$12,769,000 -115% 01 Jan 2012 31 Dec 2012 10-K 13 Mar 2015 2014 FY
2011 $11,062,000 -$1,128,000 -11% 01 Jan 2011 31 Dec 2011 10-K 07 Mar 2014 2013 FY
2010 $9,934,000 01 Jan 2010 31 Dec 2010 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.